Comprehensive overview of detecting and treating pancreatic cancer

pharmanewsdaily- June 21, 2024

Detecting pancreatic cancer effectively relies on several critical diagnostic tools. Key among them is the pancreatic biopsy, a definitive test for identifying cancerous cells. Imaging ... Read More

Understanding Pancreatic Cancer: Incidence, Symptoms, and Prevention

pharmanewsdaily- June 21, 2024

Pancreatic cancer, medically termed "Pancreatic Carcinoma," is a serious condition originating in the pancreas, an essential organ located behind the stomach. The pancreas plays a ... Read More

Exploring Marine Cytotoxic Compounds in Cancer Treatment

pharmanewsdaily- June 15, 2024

Marine organisms offer a vast reservoir of cytotoxic compounds with potential therapeutic applications in treating various cancers. These biomedicines, known as marine drugs, are derived ... Read More

Health Hazards of Smoking and Nicotine Addiction

pharmanewsdaily- June 15, 2024

Nicotine, a potent chemical found in tobacco leaves, is the primary reason people become addicted to smoking cigarettes and cigars. This substance stimulates the nervous ... Read More

Study links high doses of Vitamin B supplements to increased lung cancer risk in men

pharmanewsdaily- June 8, 2024

A study has highlighted a significant health concern for men who consume high doses of vitamin B supplements, particularly vitamins B6 and B12. According to ... Read More

Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible

Pallavi Madhiraju- March 13, 2024

In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to ... Read More

Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research

Pallavi Madhiraju- February 18, 2024

Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with XOMA Corporation, setting the stage for a ... Read More

Buckingham Palace confirms King Charles’s cancer diagnosis and treatment plan

Pallavi Madhiraju- February 6, 2024

In a sobering announcement from Buckingham Palace on Monday, it was revealed that King Charles III has been diagnosed with an unspecified type of cancer, ... Read More

Gilead Sciences invests $320m in Arcus Biosciences to accelerate cancer treatment innovations

Pallavi Madhiraju- January 30, 2024

Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) have announced a significant amendment to their collaboration agreement, accompanied by a substantial $320 ... Read More

Bristol Myers Squibb’s subcutaneous nivolumab shows promise in Phase 3 RCC trial

Pallavi Madhiraju- January 29, 2024

Bristol Myers Squibb (NYSE: BMY) has announced results from its Phase 3 CheckMate -67T trial, which could revolutionize treatment for patients with advanced or metastatic ... Read More